RY

169.48

+0.11%↑

TD

94.14

-0.12%↓

BMO

133.89

+1%↑

BNS

72.41

+0.18%↑

CM

91.45

+0.8%↑

RY

169.48

+0.11%↑

TD

94.14

-0.12%↓

BMO

133.89

+1%↑

BNS

72.41

+0.18%↑

CM

91.45

+0.8%↑

RY

169.48

+0.11%↑

TD

94.14

-0.12%↓

BMO

133.89

+1%↑

BNS

72.41

+0.18%↑

CM

91.45

+0.8%↑

RY

169.48

+0.11%↑

TD

94.14

-0.12%↓

BMO

133.89

+1%↑

BNS

72.41

+0.18%↑

CM

91.45

+0.8%↑

RY

169.48

+0.11%↑

TD

94.14

-0.12%↓

BMO

133.89

+1%↑

BNS

72.41

+0.18%↑

CM

91.45

+0.8%↑

Search

Hercules Capital Inc

Fermé

SecteurFinance

18.65 0.27

Résumé

Variation du prix de l'action

24h

Actuel

Min

18.47

Max

18.72

Chiffres clés

By Trading Economics

Revenu

61M

119M

Ventes

89M

169M

P/E

Moyenne du Secteur

10.828

26.043

Rendement du dividende

8.48

Marge bénéficiaire

70.164

Employés

100

EBITDA

18M

120M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+7.05% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

8.48%

4.04%

Prochains Résultats

12 févr. 2026

Date du Prochain Dividende

4 mars 2026

Date du Prochain Détachement de Dividende

25 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

159M

3.4B

Ouverture précédente

18.38

Clôture précédente

18.65

Sentiment de l'Actualité

By Acuity

50%

50%

182 / 525 Classement par Finance

Score Technique

By Trading Central

Confiance

Neutral Evidence

Hercules Capital Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

12 janv. 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12 janv. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12 janv. 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 janv. 2026, 23:18 UTC

Acquisitions, Fusions, Rachats

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 janv. 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 janv. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 janv. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 janv. 2026, 21:50 UTC

Market Talk
Résultats

Auto & Transport Roundup: Market Talk

12 janv. 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12 janv. 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 janv. 2026, 20:54 UTC

Résultats

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 janv. 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 janv. 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 janv. 2026, 20:18 UTC

Acquisitions, Fusions, Rachats

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 janv. 2026, 20:18 UTC

Acquisitions, Fusions, Rachats

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 janv. 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 janv. 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 janv. 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 janv. 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 janv. 2026, 19:24 UTC

Acquisitions, Fusions, Rachats

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 janv. 2026, 19:22 UTC

Acquisitions, Fusions, Rachats

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 janv. 2026, 18:21 UTC

Acquisitions, Fusions, Rachats

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 janv. 2026, 18:20 UTC

Acquisitions, Fusions, Rachats

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 janv. 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 janv. 2026, 18:16 UTC

Market Talk
Acquisitions, Fusions, Rachats

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 janv. 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 janv. 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 janv. 2026, 18:01 UTC

Acquisitions, Fusions, Rachats

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 janv. 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Comparaison

Variation de prix

Hercules Capital Inc prévision

Objectif de Prix

By TipRanks

7.05% hausse

Prévisions sur 12 Mois

Moyen 20.04 USD  7.05%

Haut 24 USD

Bas 18 USD

Basé sur 7 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

7 ratings

6

Achat

1

Maintien

0

Vente

Score Technique

By Trading Central

17.41 / 17.93Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

182 / 525Classement par Finance

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat